KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $1.5 billion.

  • Medpace Holdings' Total Non-Current Liabilities rose 1834.83% to $1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 1834.83%. This contributed to the annual value of $1.5 billion for FY2025, which is 1834.83% up from last year.
  • Per Medpace Holdings' latest filing, its Total Non-Current Liabilities stood at $1.5 billion for Q4 2025, which was up 1834.83% from $1.4 billion recorded in Q3 2025.
  • Medpace Holdings' 5-year Total Non-Current Liabilities high stood at $1.5 billion for Q4 2025, and its period low was $576.3 million during Q1 2021.
  • For the 5-year period, Medpace Holdings' Total Non-Current Liabilities averaged around $1.0 billion, with its median value being $1.0 billion (2022).
  • As far as peak fluctuations go, Medpace Holdings' Total Non-Current Liabilities surged by 6867.87% in 2022, and later crashed by 216.89% in 2023.
  • Medpace Holdings' Total Non-Current Liabilities (Quarter) stood at $689.3 million in 2021, then surged by 36.87% to $943.4 million in 2022, then increased by 13.38% to $1.1 billion in 2023, then increased by 15.23% to $1.2 billion in 2024, then rose by 18.35% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q4 2025, $1.4 billion for Q3 2025, and $1.3 billion during Q2 2025.